Why Vaxcyte, Inc. (PCVX) stock moved
Vaxcyte, Inc. (PCVX) shares rose 0.3% to $56.20 as of July 18, 2026, a slight gain from the prior close of $56.04. BestStocks flagged the session as a major change for PCVX. The move is tied to a new SEC filing. Below, we break down what changed for PCVX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
SEC Filing
Vaxcyte, Inc. (PCVX) filed a new 8-K on July 15, 2026. The audit found the filing announcement but did not disclose the specific event or material information contained in the filing. Review the full 8-K filing on the SEC's EDGAR system to identify the material event disclosed.
What it means for Vaxcyte, Inc. investors
For Vaxcyte, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive 0.3% session move; Vaxcyte, Inc. (PCVX) moved +4.12% from $56.08 to $58.39 on 2026-07-02, reaching a new 30-day high. Weighing against that: Vaxcyte, Inc. (PCVX) moved -2.71% from $59.83 to $58.21 on 2026-07-10; PCVX moved -3.23% from $60.67 to $58.71 on 2026-07-08. Wall Street's consensus price target sits at $89.00, implying +58.4% upside from $56.20. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 18 days out, the next report is the most likely near-term test of the move.
PCVX price reaction
PCVX last traded at $56.20, up $0.16 (+0.29%) from the previous close of $56.04. The session traded on 0.6× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on Vaxcyte, Inc. (PCVX)
The consensus analyst price target on Vaxcyte, Inc. (PCVX) is $89.00, 58.4% above the recent $56.20. Here is how the bullish and bearish cases on PCVX line up.
The bullish case
- Wall Street's consensus price target of $89.00 implies +58.4% upside from $56.20.
- The Street's most bullish target is $89.00 (+58.4%).
- Positive 0.3% session move.
- Vaxcyte, Inc. (PCVX) moved +4.12% from $56.08 to $58.39 on 2026-07-02, reaching a new 30-day high.
The bearish case
- Vaxcyte, Inc. (PCVX) moved -2.71% from $59.83 to $58.21 on 2026-07-10.
- PCVX moved -3.23% from $60.67 to $58.71 on 2026-07-08.
- PCVX declined 4.35% intraday to $55.60 on below-average volume (0.47x expected).
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 18, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for PCVX
Frequently asked questions about PCVX
Why did Vaxcyte, Inc. (PCVX) stock move?
PCVX rose 0.3% to $56.20. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did PCVX stock rise?
PCVX gained 0.29% ($0.16) versus the prior close of $56.04, last trading at $56.20 on 0.6× average volume.
When is Vaxcyte, Inc.'s next earnings date?
PCVX's next earnings report is estimated for 2026-08-05 — about 18 days away.
What is the analyst price target for PCVX?
The consensus analyst price target for PCVX is $89.00, about 58.4% above the current $56.20. Over the past 90 days, analysts recorded 0 upgrades, 0 maintains, and 0 downgrades.
How BestStocks tracks PCVX
This page is generated automatically by BestStocks' change-detection system after a new SEC filing was detected and verified against independent data sources. It draws on 7 tracked change events for PCVX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 18, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.